Geology ReportsSearch

Geology topics

Samantha L. Wolfe

Publications and source records attributed to Samantha L. Wolfe.

4 recordsLinked to original sources

Evaluation of the acute toxicity of the piscicide TFM to Burbot

Non-target animal sensitivity remains a concern when treating Laurentian Great Lakes streams with 4-nitro-3-(trifluoromethyl)phenol (TFM), the main pesticide used to control Sea Lamprey Petromyzon marinus as part of the bi-national Great Lakes Fishery Commission's Sea Lamprey Control Program. Populations of Burbot Lota lota , a historically and culturally important fish, inhabit some of the streams that are treated with TFM. While many species of fish inhabiting the Great Lakes streams have been assessed for sensitivity to TFM, we are not aware of previous research to assess the risk to Burbot. We assessed the sensitivity of Burbot to TFM using replicate 12-hour flow-through diluter toxicity tests. We found Burbot to have a median lethal concentration (LC 50 ) of 9.74 mg/L, while the minimum lethal concentration (LC 99.9 ) for Sea Lamprey was predicted to be 2.5 mg/L in similar waters. The resulting toxicity ratio (LC 50 of non-target organism/LC 99.9 of Sea Lamprey) of Burbot was 3.90, well above the toxicity ratios for known sensitive species. Our results suggest Burbot are not expected to be adversely affected during a typical TFM stream treatment.

Great Lakes

Comparative toxicity of emulsifiable concentrate and suspension concentrate formulations of 2′,5-dichloro-4′-nitrosalicylanilide ethanolamine salt

The 2-aminoethanol salt of niclosamide (2′,5-dichloro-4′-nitrosalicylanilide) is a pesticide known as Bayluscide that is used in conjunction with TFM (4-nitro-3-[trifluoromethyl]phenol), also known as 3-trifluoromethyl-4-nitrophenol) to treat tributaries to the Great Lakes infested with invasive parasitic Petromyzon marinus (sea lamprey). Adding 0.5 to 2 percent Bayluscide with TFM can substantially reduce the amount of TFM required to achieve effective control. Currently, an emulsifiable concentrate (EC) formulation of Bayluscide is used in combination with TFM during some stream treatments completed by the Great Lakes Fishery Commission’s binational sea lamprey control program. The Bayluscide EC formulation is highly effective; however, it degrades application tubing, adheres to application equipment, and raises concerns for worker safety because of the solvent in the formulation, N-methyl-2-pyrrolidone. We collaborated with a pesticide formulation company to develop a Bayluscide 20-percent suspension concentrate (SC) formulation as a potential replacement for the Bayluscide 20-percent EC formulation. The 20-percent SC formulation was specifically developed using inert ingredients approved for use by the U.S. Environmental Protection Agency and the Health Canada Pest Management Regulatory Agency. Although approved for use, the inclusion of a small quantity of an antimicrobial in the formulation warranted evaluating the toxicological profile to sea lamprey and select nontarget fish species. We evaluated and compared the toxicity of the 20-percent SC formulation to the 20-percent EC formulation using continuous-flow diluter systems and larval sea lamprey and select cold-, cool-, and warm-water fish as test animals. Our results demonstrate comparable toxicological profiles between the two formulations with the 20-percent SC formulation being slightly less toxic to the nontarget species evaluated.

Open-File Report

Seasonal differences in larval sea lamprey (Petromyzon marinus) sensitivity to the pesticide TFM

Invasive sea lamprey ( Petromyzon marinus ) are controlled in the Great Lakes with 4-nitro-3-(trifluoromethyl)phenol (commonly 3-trifluoromethyl-4-nitrophenol or TFM). The proper amount of TFM must be applied during treatments to effectively kill larval sea lamprey while minimizing impacts to non-target species. In this study, bioassay tests were conducted in May, July, and September in a portable test trailer at six larval sea lamprey infested rivers in Michigan to determine potential seasonal changes in sensitivity of larval sea lamprey to TFM. Larvae greater than 60 mm were collected from each stream and exposed for 12 h in TFM-treated stream water using two independent continuous-flow diluter systems. A suite of water chemistries and larval physiological parameters were collected during the tests and modeled as potential predictors of seasonal changes in the sensitivity of larval sea lamprey to TFM. The observed minimum lethal concentrations to larval sea lamprey were 0–40% lower (May), 8% lower–59% higher (July), and 49–117% higher (September) than sea lamprey control personnel treatment prediction charts. Water temperature, liver glycogen content, and time of year were strongly associated with seasonal differences in TFM sensitivity, offering sea lamprey control personnel more exact predictions to limit potential residual lamprey surviving future treatments.

Michigan

Efficacy of florfenicol and oxytetracycline administered in feed to control cisco mortality associated with Aeromonas salmonicida infections

Two medications (one with florfenicol and one with oxytetracycline) that are approved in the United States to control mortality due to furunculosis associated with Aeromonas salmonicida were assessed to determine their efficacy in medicated feeds to treat A. salmonicida -infected Cisco (also known as Lake Herring) Coregonus artedi . Cisco were subjected to static infection baths containing A. salmonicida or a sham control and then were distributed to replicate test tanks within four treatment groups: (1) fish infected with A. salmonicida and treated with 15 mg florfenicol·kg body weight (BW) −1 ·d −1 , (2) fish infected with A. salmonicida and treated with 83 mg oxytetracycline·kg BW −1 ·d −1 , (3) fish infected with A. salmonicida and treated with a nonmedicated control feed, and (4) uninfected fish treated with a nonmedicated control feed. Medicated and comparative nonmedicated feed rations were administered at 2% BW/d for 10 consecutive days in accordance with the U.S. Food and Drug Administration-approved drug label, followed by a 7-d postdosing observation period using only nonmedicated feed. Cisco that were infected with A. salmonicida and treated with florfenicol (79% survival) and oxytetracycline (85% survival) had significantly higher survival than A. salmonicida -infected fish that received no medicated treatment (3% survival). No statistical difference in Cisco survival between the two medicated feed types was found. Aeromonas salmonicida was not detected in the kidney tissue of any surviving fish treated with medicated feeds at 7 d postdosing using quantitative PCR analysis. Overall, this study demonstrated that florfenicol- and oxytetracycline-medicated feeds were effective A. salmonicida treatments for Cisco. Outcomes may inform ongoing propagation efforts for Cisco restoration within the Great Lakes basin.

North American Journal of Aquaculture